At the ongoing Hannover Messe, The Cultivated B and Siemens have teamed up to present advancements in biomanufacturing for the alternative protein sector. The companies are showcasing their AUXO V® bioreactor, a key technology aimed at scaling alternative protein production through economically sustainable methods.
“I consider Siemens […] the partner with whom we can synergize towards any collaboration”
n!Biomachines, a subsidiary of The Cultivated B, is at the forefront of developing bioreactors designed for the food industry and other sectors. These bioreactors play a central role in producing proteins traditionally sourced from animals, but through biomanufacturing methods that eliminate the need for animal agriculture. The bioreactors are built with an emphasis on scalability, precision, and ease of use, allowing for the transition from lab-scale production to industrial-level output.
Hamid Noori, CEO of n!Biomachines, commented on the partnership with Siemens, stating, “I consider Siemens a trustworthy partner, a reliable partner for our sustainability strategies, and the partner with whom we can synergize towards any collaboration.”
The collaboration between n!Biomachines and Siemens demonstrates the integration of Siemens technology to simplify the operation of complex bioreactor systems. More than 100 Siemens components are embedded in the system, providing the control systems and electronics needed to ensure smooth performance. The user interface of the bioreactor has been designed to be intuitive, with pre-programmed recipes that make the technology accessible to users across various knowledge levels.
Exploring global food system challenges
As part of the event, Noori will join Joris Myny, senior vice president of digital industries at Siemens Canada, for a panel discussion. The discussion will focus on the global challenges within the food system and how both companies are working together to address them. Canada is the featured partner country at this year’s Hannover Messe, with a delegation led by NGen Canada.
The focus of this collaboration is not only on scaling the production of alternative proteins but also on making the biomanufacturing process safer and more environmentally sustainable. Valerie Ward, associate professor and Canada research chair at the University of Waterloo, noted, “Technology like this helps enable us to produce those types of products that are safer, more environmentally friendly and better for end users.”
